Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

60.16
-0.9607-1.57%
Volume:154.75K
Turnover:9.35M
Market Cap:8.36B
PE:-8.38
High:61.06
Open:60.31
Low:60.03
Close:61.12
52wk High:88.31
52wk Low:54.30
Shares:139.02M
Float Shares:138.02M
Volume Ratio:0.48
T/O Rate:0.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-48.21
PE(LYR):-9.20

Loading ...

Mar 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 10, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 11, 2025

Major Issues Report

Form 8-K - Current report
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2024

Major Issues Report

Form 8-K - Current report
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 19, 2024

Major Issues Report

Form 8-K - Current report
Nov 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]